Q3/2019 9/30/2019 EPS 0.400 ZacksConsensus 0.100 ActVsEst 0.300 - Beat
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $1.00 price target on the stock, down previously from $7.00.MarketBeat
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $0.70 price target on the stock, down previously from $8.00.MarketBeat
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Leerink Partners from $3.00 to $1.00. They now have a "market perform" rating on the stock.MarketBeat
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.MarketBeat
- Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on ApraglutideBusiness Wire
IRWD
Earnings
- 2/27/25 - Miss
IRWD
Sec Filings
- 4/14/25 - Form 8-K
- 4/4/25 - Form 4
- 3/31/25 - Form 10-K
- IRWD's page on the SEC website